Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HHS
In the long run I think your gonna be right, in the short run, I don't think this is the quarter to bet on. This is a seasonally weak quarter generally and lets face it sales are still showing significant y/y declines as of right now. I do think that will turn positive in the 2nd half of the year, but right now we are in q1. The thing that is changed for me why I decided to sell is I now really feel q1 is generally seasonally weak, hence I don't see it going up if they show a slight loss or slight profit. Maybe I'll be completely wrong, but my gut is telling me get out now so I did. Time will tell. All is just my opinion, and I could always be wrong though.
HHS
Decided to sell my small position with shares here and there of HHS over the last week at $7.07 and higher. Took a small profit. I thought about it and I don't think q1 is gonna be anywhere as good as q4. Seasonally q1 tends to be a weaker quarter, if they report a loss, and I do believe in the longer-term thesis but after further review I believe the stock could get hit in the short-run, hence I probably will be looking to buyback, I just don't think q1 will be pretty, and I think the stock could be lower than current prices. Maybe I'll be wrong, but my gut is telling me I'll be able to buyback cheaper in my opinion.
HALO
Clearly could of timed it better by selling this morning. I still think it will see the high 30's in the coming weeks. I was disappointed with the revs in q1 and some of the guidance for q2. I do still believe in the longer run the stock will go higher than where I sold. All is just my opinion, and I could always be wrong though.
Reasercher59, as you said the cost basis is shown by lot. I have to be honest since I generally sell my whole position more times than not, never looked into the tax feautures because it never really applies to me. Hope this helps. All is just my opinion, and I could always be wrong though.
IART
This is standard operating procedure. When a stock falls off a cliff the analysts take down there price targets. This isn't a IART thing it happens all the time, if IART stock starts going up the price target will suddenly climb out of nowhere (Which is why I don't have much value on analyst price targets). But if you read the post researcher had on it today, reading between the lines they don't believe the company will hit guidance. In fairness I think the reaction by the market at this point is like you told us about Boston a year ago, a year later your more clueless than a year ago. so why should I trust anything you say. They have to show they should be trusted at thispoint, they cannot come in and tell us they need to lower guidance again, and they haven't figured out the integra skin business. After awhile you have to do something right. Now I think they will and management although having other problems, I think has no clue how to fix boston, but the rest of the business they have a firm handle on. Could I be wrong we will find out. The good news is we now know Boston isn't gonna be the thing that destroy guidance or the share price this time, everyone is factoring boston completely out at this point. All is just my opinion, and I could always be wrong though.
SSKMP Managed Index (As Of 5/7/24)
Daily Performance
+0.49%
YTD Performance
+1.22%
Overall Performance
+477.50% (Including Options Trading +341.48%)
VMIR (As Of 5/7/24)
Daily Performance
Value Microcap Index:-0.17%
Value Microcap Index Rebalanced:-0.66%
Overall Performance
Value Microcap Index: -0.37%
Value Microcap Index Rebalanced:+2.19%
VMIR (As Of 5/7/24)
Daily Performance
Value Microcap Index:-0.17%
Value Microcap Index Rebalanced:-0.66%
Overall Performance
Value Microcap Index: -0.37%
Value Microcap Index Rebalanced:+2.19%
~~COMPX 5/8/2024~~~~~~~
Previous Close
16,332.56 -16.69
16199 SSKILLZ1
HALO
I was selling my shares here and there AH. They missed on revenues, and In the CC royalities are suppose to be flat sequentially I think I heard. I was under the opinion they would hit the high end of revs, and possibly beat the eps number. Now I think they will hit the lower end of revs, and eps will be within the range. HALO is up against resistance in the $42-43 range., and I don't think a .79 quarter with a miss on the top line, will be enough to break it through resistance. I Basically had a average cost of about $34 and sold about $42 avg, so I had a nice profit. clearly they are going to be heavy back half weighted, was a litte disappointed not to see a ramp up in q2, and thought revs would be a little better in q1. I will buyback on weakness say somewhere around $37-38 I would be a buyer again. Anyways time will tell if I'm making the right decision. All is just my opinion, and I could lways be wrong though.
Valuemind for what it's worth I was being sarcastic with surprise, surprise. LOL.
IART
I can't say I deserve any congratulations as the stock has been a unmitigated disaster since I brought it overall. What I found funny today is the analyst were in a rush to downgrade it this morning and lower price targets and surprise, surprise, the stock actually troughs from the absurd overreaction to the stock yesterday in my opinion.
SSKMP Managed Index (As Of 5/6/24)
Daily Performance
-0.73%
YTD Performance
+0.73%
Overall Performance
+475.36% (Including Options Trading +339.34%)
VMIR (As Of 5/6/24)
Daily Performance
Value Microcap Index:+0.77%
Value Microcap Index Rebalanced:+1.17%
Overall Performance
Value Microcap Index: -0.20%
Value Microcap Index Rebalanced:+2.87%
VMIR (As Of 5/6/24)
Daily Performance
Value Microcap Index:+0.77%
Value Microcap Index Rebalanced:+1.17%
Overall Performance
Value Microcap Index: -0.20%
Value Microcap Index Rebalanced:+2.87%
~~COMPX 5/7/2024~~~~~~~
Previous Close
16,349.25 +192.92
16199 SSKILLZ1
BCBP
The insider buying is a plus. As with everything there are pluses and minues.
BCBP Earned .32 down from .46 this time last year. Hence can't say that is a positive. But let break down all the metrics to get a better understanding of what is going on here.
Loan Growth and Deposit Growth Loan growth was down slightly sequentially and y/y. As for depsoti growth it has been going slightly higher and quite frankly that happened again in q1. All and all nothing here bothers me.
NIMS Otherwise known as Net interest margin, as one knows this has been dropping for all banks, I am looking for stabilization at this point, and eventually an increase of nims in the coming quarters on the banks i want to buy. The good news is nims went from 2.57% last quarter to 2.50% this quarter, which isn't good at face value, but it had a much slower drop than the previous quarter going from 2.78% to 2.57%, so maybe getting close to troughing. Obviously can't know that for certain, but that would be a plus if it stops going down, right now can't say that though as 1 number is not a trend and it was still going down, so need to see if nims comes in around here next quarter or it declines. Right now NIMS trend is still a negative, but it would be a plus if it is starting to trough for profitability and top line going foward. Not sure yet here if that is the case.
Book value Trades at steep discount too book, so that is a plus.
Dividend Pays a nice divy, than again not thrilled that the payout ratio is approaching 50% on current earnings. That too me is not a plus, although the divy is. How safe that divy is, if this continues is a slight concern.
Asset quality here is the thing that has kept me away from BCBP. Look at the trend of not just non accural Loans, but classified loans. Now clssified loans don't have to go bad, but they are seen as much higher risk, the number was just 17 million in q1 last year, now over 97 million in q1 this year, that is a huge increase. Of course Non accural have gone up significantly and based on what I think will happen they may go up alot further in future quarter would like to see some stabilization with some of these metrics first. Right now I see these numbers going up which is obviosuly a negative. Don't get me wrong asset quality is weaker for alot of banks than it was a year ago, and some of that is that it is coming off numbers where therere were very low levels of bad loans, but in this case, just see these numbers going up a bit faster than I would expect even in that environment.
Now why we should care is BCBP at some point might need to take larger provisions than say 2 million a quarter, and that has to be a concern. Plus asset quality is always the most important thing when you look at a bank.
All and all I would pass as I like numerous banks better than this. Asset quality is very important to me, the metric could be better and i'm being nice, specifically with the trend. Loan and deposit growth is non existant. don't think this should trade at much more than 10 multiple if that, and quite frankly wouldn't surprise me if earnings are under .30 next quarter, hence in the mid 10's it is near FV for me. The divy although great, the payout ratio is approaching 50% which doesn't make me thrilled either. The only real positive I see right now is the discount too book. Barring on the off chance of it being acquired (Not a reason to invest), the stock should remain at a steep discount too book until the EPS Numbers stop declining (if I had to guess next quarter would be under .30) so that would continue the trend of declining, and asset quality gets better which right now the metrics are getting worse. I'll pass, but I wish you the best with it. All is just my opinion, and I could always be wrong though.
SSKMP Trades
Buy 300 Shares of IART
Note that this is a fictional portfolio and is not a recommendation to buy or sell securities
Both went they cut two to take it from 7 to 5. Hope this helps.
Here's your answer. Hope this helps.
The Actual Bottom 2
Mckennah- Can't say I'm surprised after being saved last week by the judges. Clearly wasn't popular.
Julia- Was a little more surprised on her figured Emmy had to go eventually, but just like contestant go because they are unpopular, some stay for the exact same reason, that can be said about emmy. As for Julia, she did have a not very good 1rst performance which didn't help her either.
IART
I always believe you have to take a look at line by line. For me Amortization is a expense I ex out. Analyst ex it out, it is not like IART is the only one to do this. Tons of companies do this in many industries. Obviously amortization will be higher for companies that are more acquisitive in nature. Not a shocker. The Boston issues, well that should be an adjustment, acquisition expenses for making an acquisition not debating that. The only one that I have to admit, by the way plenty of Medical device companies ex this expense out so it is not a IART thing, but I do admit the EU expense thing I do question in the adjusted number. And I do admit if you look at it that way than maybe $2.90-3.00 for fy 25. So if you want to say I'm too optimistic, than I could make a case for low 40's because that is actually a real expense too me. Than again. All again most of the medical device makers add that expense back to there numbers as well. Hence if you don't think that should be added in, the medical device space even trade at a higher pe than we thought. hence IART is still absurdly cheap to it's sector. Time will tell. All is just my opinion, and I could always be wrong though.
IART
The answer is simple it can be said in one word. Credibility The market/analysts I don't think Believes management right now, and they are wondering what other problems they are gonna come across. Keep in mind Boston happened over a year ago, and they sound more in the dark today than they did a year ago, how is that possible. That is going to put a black cloud over the entire company. Fair or not. Analyst downgrades are a coming (Which is very useful at this point (foaming with sarcasm)), Lower Price tragets are also coming. I didn't think it would drop anywhere near this far (Otherwise I would of sold in the morning), but to be honest the seller is constantly had momentum, and it clearly has picked up momentum today as the stock much lower now than I thought it would be. All is just my opinion, and I could always be wrong though.
My Take on the show last night
Round 1
1) Jack- not my favorite song. But I thought he sang it well, and had fun performing. Not normally his style. But it worked for me. I thought it was very good. Grade B+
2) Julia- As one knows I'm normally a fan, but this in my opinion was one of her weaker performance to date, if not her worst. Lots of pitch issues and yelling. Below average performance. Grade D+
3) Abi- Singing a FOB Song. Got to say she did a great job not getting thrown off by catching the equipment that came lose. She did a great job performing and a near excellent vocal for me. Grade A-
4) Mckennah Singing a KP Song. Overall I thought the vocal was very good. The bad news is the performance was a bit stiff. So I take a little away from that. Still good though. Grade B
5) Will- I thought the vocal was good, the song however was bit boring though for me. Thought the overall performance was solid. Grade B-
6) Emmy- Her tone doesn't sound very good. Didn't like her changes on the arrangement. How the way she sang it is suppose to make you want to dance I will never know. The judges loved it again, I just don't get it. Well below average vocal and performance for me. Grade D
7) Triston- Singing a TT Song. In my opinion he is getting worse. Alot of the song I thought his voice was drowned out by the band. And in other parts I don't think he was very clear either. In parts felt like I was getting every 3rd word. Just barely average for me. Grade C
Round 2
1) Mckennah- A Little bit boring and draggy, a decent vocal, but not great either. Slightly above average, but nothing better than that. Grade C+
2) Jack-I tought he did a very good job on that song. Very good vocal and performance. Grade B+
3) Will- Singing one of my favorite songs from this songbook. Having said that will seemed off in parts, one of his weaker performances to date. Just barely average and I'm being nice. Grade C
4) Julia- Singing another one of my favorite songs from this songbook. As for Julia, not perfect, but still good for me. Grade B
5) Emmy- Much better than her first performance, granted the bar was really low to surpass that. Her tone/vocal didn't bother me as much on this song overall. Just average for me. Grade C
6) Triston- Seemed flat in the beginning, and than the middle to the end was just okay. Just average at best. Grade C
7) Abi- Singing another one of my favorite songs from this songbook. This was another near excellent vocal for me, she did it differently, but it still sounded very good. Grade A-
My Bottom 2
Emmy-she is the weakest singer out of the group and it isn't even close.
Triston- I have not been a huge fan recently as his performances seem to be getting weaker for me. Although I acknowlege he had no shot being in the bottom 2 as I thought he was waaaaaaaaaaaaaay too popular.
The Actual Bottom 2
Mckennah- Can't say I'm surprised after being saved last week by the judges. Clearly wasn't popular.
Julia- Was a little more surprised on her figured Emmy had to go eventually, but just like contestant go because they are unpopular, some stay for the exact same reason, that can be said about emmy. As for Julia, she did have a not very good 1rst performance which didn't help her either.
Anyways that is my take on the show. All is just my opinion of course.
IART and The CC
Brought a bunch more IART at $22.89 today. Here is what I think.
Boston
First let me start on Boston, this is the unmitigated disaster, Now Who knows if it comes back at all at least sometime in 2025. Possible different Location, one thing that is obvious is that $3.60 estimate is now bye bye in my opinion, although even without Boston I expect FY 25 to be a year of growth from fy 24 numbers (So still thinking $3.30-3.40 even with no Boston). But can't act like the thesis didn't take a hit today, the thesis was Boston being a part of this which is why I thought the $3.60 even had upside, clearly now can't include boston in my mind even in fy 25 in the analysis), and who knows when that is coming back at this point of if it is coming back? Or a possible different location at this point.
The Guidance
Of $3.01-3.11, I actually was worried it could be worse in my worst case scenario, I thought that was a positive now that boston is completely out of the numbers, and the numbers held up better than I thought they would. Keep in Mind they are having higher costs from Boston (Fixing the problems), with no revs, so that is the main reason for lowering of guidance. To be fair it has become obvious to me supply chain is also a problem some thanks to Boston obviously, but there integra skin business has had trouble meeting demand. Now the positive the demand is there, the negative is they have not been able to meet the demand yet, but the facilities for this are at least ramping up more, not hopes of someday in the future but it is actually in the process of happening and is online allready with capacity expansion underway. The integra skin business they believe will start really ramping up in the 2nd half meeting demand. Margins should improve a bit sequentially, but still be down y/y because of the expenses with boston and some supply chain issues. Further improvement will happen in fy 25 and beyond on the margin front.
Now the good news is guidance shows that there is gonna be really good growth in the 2nd half y/y, if they hit the numbers the stock will massively rebound. if they don't than I will be completely wrong an take a tax loss at the end of the year that is how I plan to play this stock. I actually believe the numbers now show extra costs from boston, I also think in the second half they are gonna be a 5-7% grower of revs (Organically) and more on profits from q3 on, even without boston. Shows you how well those number would of looked if Boston hasn't been a disaster, there is no way to sugercoat this.
I still think it will receive a lower level sector pe in a year, if they have no further issues, so I still think it will get a mid teens multiple. But now I feel FV is probably around $50 instead of $60.
Now IART Should return to growth in the 2nd half, right now I don't think the market believes that is going to happen without boston,but the thing is this company is a mid single digit grower organically and will start to show that in the second half, because they are now comping out boston revs in y/y comps.
Now the Acclarent business they acquired sounds promosing. They think it will grow high single digits like in FY 25 and beyond is what I heard. Obviosuly the ENT business will be like a third unit from them. Granted it i supposed to be around neutral to adjusted eps this year, and my understanding accretive going foward. Wouldn't surprise me if it is another slight headwind buried in q2 numbers and most likely improve after that. Than again that is just a guess as it really wasn't broken down.
All and all your getting a company that even without boston probably in fy 25 could earn say $3.30-3.40, and a company that will return to mid single digits organic revenue growth, with high single digits to low double digits eps growth going foward. For less than 8 times this years revised numbers and about 7 times what I think they can earn in fy 25 even if Boston disappears. The positive is the rest of the business if anything is stronger than I expected, the bad news is I thought Boston would definetely be around in fy 25. Mangement now has an issue that I don't think anyone believes there guidance. They are gonna have to come in q2 and reiterate guidance, and not drop anymore negatives. The stock will stabilize and start going up, I think the market has hit this company today so hard, because of who knows on Boston, but also I think who believes in management. It is clear to me they had no clue on Boston, and they still don't. It is also clear to me there rest of there business is running well and if anything slightly better than I thought, since they have kind of exed boston out completely now I have more confidence they will hit the numbers now, the market and the analysts are having an issue believeing them right now, and although I do at this point, I understand why not for the analysts. All is just my opinion, and I could always be wrong though.
Drug stocks and Medical device stocks are very different, so that logic seems very flawed to me in my opinion.
IART
Valuemind, the Boston facility is costing them because there have been tons of expenses as well as lost revs. My understanding is it is about .40 eps annually, that is significant. Furthermore IART if they hit there fy 25 numbers of say $3.60 plus is trading, which would be less than 8 times next years numbers for a medical device maker. That historically trade at say 15x or greater, lot of times much greater historically. Also keep in mind the Boston facility generally produces higher margins products so it has hit margins, and NI Greater than the 5% you mention.
I strongly disagree with you on IART, this has all been about Boston it has been a disaster. Nobody says I won't be wrong and it continues to be a disaster. But if Boston comes back, growth turns positive, the Multiple gets a medical device valuation and the stock essentially at least doubles from here within a year. Now if they have a disaster tomorrow, and they tell us the Boston Facility has no hope or it is gonna be a long time yet (Don't expect them to say that, but you never know), and they lose all credibility what so ever, than the whole case of the thesis falls apart.
IART has declined because of Boston this has been going on for a year, and people are questioning alot of things like does management know what they are doing, and if I'm wrong tomorrow I'm gonna be questioning that too myself. But make no mistake multiple come in when you have negative comps (That is all they have been reporting lately), multiple expand when you have positive comps. If you think Boston is coming back with the expenses out of way than FY 25 is gonna have very positive comps, if it doesn't than the IART investors (Like Myself) will be proven wrong and it will not be pretty, in fact the picture is allready not pretty. All is just my opinion, and I could always be wrong though.
To be fair to ottovino. he should of been out the inning with that groundball that they got nobody. But also to be fair that is alot on ottovino as well for not covering 1rst. But the walks have killed the mets all year.
Having said all that another game where they didn't hit when a pitcher pitched well. This lineup should be much better than they are. And that is the concern.
Here the info. Including the link to the new board. Hope this helps.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174317393
He looks really good. Mets tend to go after teams bullpens this year so this is generally when they go to work.
Lets see where they are after 50 games and 100 games. With oakland the answer is the bullpen has been phenominal (Don't know if it sustainable), and I truely believe they will trade good bullpen arms anyways at the deadline, because I think they will be under .500, and than they will fall off in the 2nd half when they trade away pieces for prosepcts. Still think they will lose 90 games when it is all said and done in my opinion,
In fairness in triple A he would give up the runs in the 1rst he gave up and than no more. So going according to the same playbook in the big leagues. I like the fact that he was able to settle down after the first several batters. He has very good stuff in my opinion. Obviously way way too early, but I do like the stuff in my opinion.
I think he would look better in a mets uniform in 2025. Don't you agree. LOL.
Speaking of organzations that I would be ashamed of if I was a fan of them. Dumping salary allready, with Luis Arreaz (A excellent hitter, one of the few they have). They don't do this stuff in any other sport like this. Not that they have much to sell, but selling in the beginning of may is absurd in my opinion.
More importantly I'm looking foward to Christian Scott debut tonight.
Didn't the Yankees try to change how he pitched if I remember correctly. Of what pitches he should throw. Why in the world would you try and change a successful pitchers pitches. if true that was the problem when he was with the yankees, not that it was NY.
VMIR
The VMIR is Up +1.68%, after this week’s performance. So without further ado the info is below. Remember This Index Is showed in dollar terms.
The 77 Original Stocks ($1,000.00)
Symbol Value Of Investment
ACCO $802.63
AESI $1,275.84
AMRX $1,113.67
AMS $1,248.21
ARI $856.05
ARMN $1,254.19
AVNW $915.80
BBW $1,302.74
BGS $1,084.76
BGSF $938.30
BLMN $909.77
BWFG $795.23
BZH $819.77
CAL $1,203.06
CBBI $966.67
CCSI $465.85
CMRE $1,198.85
CODI $965.70
CPLP $1,176.06
TBRG $761.61
CRNT $1,407.41
CRWS $1,024.19
CUBI $837.38
CXB.TO $1,416.40
CZWI $929.12
DIN $882.78
DNG.TO $1,280.17
DOLE $1,012.21
DRX.TO $2,010.12
EAT $1,273.27
EFSC $882.19
EXSR $1,000.00
FFBB $1,131.87
FISI $838.03
FNLC $818.21
FSBW $887.45
GIII $841.38
HAFC $814.43
HASI $941.99
HHS $1,047.13
HOT-UN.TO $731.62
HRZN $896.74
HZO $663.50
IMKTA $837.10
IMXI $912.18
INN $930.06
IVR $1,028.22
KOP $858.45
MD $1,003.23
MNDO $1,084.18
MODV $613.78
MSBI $861.76
NMM $1,588.70
NOG $1,085.78
OPBK $886.76
OPY $988.14
PERI $416.59
PKBK $831.60
PKOH $966.99
PLPC $946.88
PPBN $1,132.86
PRDO $1,386.10
PSIX $1,073.17
RCMT $672.18
REI $1,301.37
RMAX $578.39
RPAY $1,209.60
SAH $1,003.91
SBH $811.75
SKAS $1,104.52
SLRK $963.51
SVC $716.63
ULH $1,517.84
USMT $931.34
VIRT $1,112.54
VLGEA $1,096.07
VTLE $1,135.41
Average Return $77,209.92
Additions Total Value Now
AHCO $1,506.17
EMBC $627.65
FEIM $1,004.93
IBEX $799.33
NECB $1,021.14
PCRX $884.93
REPX $1,189.64
TITN $904.86
Total $7,938.66
Additions Total Value Now
ADEA $942.94
ELTK $823.42
IMMR $1,151.81
INMD $863.43
VVX $1,439.04
Totals $5,220.64
Additions Total Value Now
BUKS $1,213.87
CVGI $1,042.27
CZFS $999.97
JAKK $848.01
Totals $4,104.12
Additions Total Value Now
AUDC $1,181.34
CTUY $1,175.71
FONR $1,198.64
FOR $1,253.05
FRBA $1,205.28
INBK $1,195.12
Totals $7,209.15
VMIR
The VMIR is Up +1.68%, after this week’s performance. So without further ado the info is below. Remember This Index Is showed in dollar terms.
The 77 Original Stocks ($1,000.00)
Symbol Value Of Investment
ACCO $802.63
AESI $1,275.84
AMRX $1,113.67
AMS $1,248.21
ARI $856.05
ARMN $1,254.19
AVNW $915.80
BBW $1,302.74
BGS $1,084.76
BGSF $938.30
BLMN $909.77
BWFG $795.23
BZH $819.77
CAL $1,203.06
CBBI $966.67
CCSI $465.85
CMRE $1,198.85
CODI $965.70
CPLP $1,176.06
TBRG $761.61
CRNT $1,407.41
CRWS $1,024.19
CUBI $837.38
CXB.TO $1,416.40
CZWI $929.12
DIN $882.78
DNG.TO $1,280.17
DOLE $1,012.21
DRX.TO $2,010.12
EAT $1,273.27
EFSC $882.19
EXSR $1,000.00
FFBB $1,131.87
FISI $838.03
FNLC $818.21
FSBW $887.45
GIII $841.38
HAFC $814.43
HASI $941.99
HHS $1,047.13
HOT-UN.TO $731.62
HRZN $896.74
HZO $663.50
IMKTA $837.10
IMXI $912.18
INN $930.06
IVR $1,028.22
KOP $858.45
MD $1,003.23
MNDO $1,084.18
MODV $613.78
MSBI $861.76
NMM $1,588.70
NOG $1,085.78
OPBK $886.76
OPY $988.14
PERI $416.59
PKBK $831.60
PKOH $966.99
PLPC $946.88
PPBN $1,132.86
PRDO $1,386.10
PSIX $1,073.17
RCMT $672.18
REI $1,301.37
RMAX $578.39
RPAY $1,209.60
SAH $1,003.91
SBH $811.75
SKAS $1,104.52
SLRK $963.51
SVC $716.63
ULH $1,517.84
USMT $931.34
VIRT $1,112.54
VLGEA $1,096.07
VTLE $1,135.41
Average Return $77,209.92
Additions Total Value Now
AHCO $1,506.17
EMBC $627.65
FEIM $1,004.93
IBEX $799.33
NECB $1,021.14
PCRX $884.93
REPX $1,189.64
TITN $904.86
Total $7,938.66
Additions Total Value Now
ADEA $942.94
ELTK $823.42
IMMR $1,151.81
INMD $863.43
VVX $1,439.04
Totals $5,220.64
Additions Total Value Now
BUKS $1,213.87
CVGI $1,042.27
CZFS $999.97
JAKK $848.01
Totals $4,104.12
Additions Total Value Now
AUDC $1,181.34
CTUY $1,175.71
FONR $1,198.64
FOR $1,253.05
FRBA $1,205.28
INBK $1,195.12
Totals $7,209.15
VMI/VMIR Differential Chart
VMI VMIR Differential
1/5/2024 -1.04% -1.04% 0.00%
1/12/2024 -2.63% -2.63% 0.00%
1/19/2024 -3.07% -3.07% 0.00%
1/26/2024 -0.64% -0.64% 0.00%
2/2/2024 -2.47% -2.14% 0.33%
2/9/2024 -2.47% -1.91% 0.56%
2/16/2024 -0.97% -0.24% 0.73%
2/23/2024 -2.63% -1.27% 1.36%
3/1/2024 -1.11% 1.04% 2.15%
3/8/2024 -1.88% 1.91% 3.79%
3/15/2024 -2.47% 0.95% 3.42%
3/22/2024 -1.86% 1.46% 3.32%
3/28/2024 0.76% 4.51% 3.75%
4/5/2024 -1.17% 1.82% 2.99%
4/12/2024 -3.51% -0.76% 2.75%
4/19/2024 -3.87% -1.29% 2.58%
4/26/2024 -1.63% 0.64% 2.27%
5/3/2024 -0.96% 1.68% 2.64%
VMI/VMIR Differential Chart
VMI VMIR Differential
1/5/2024 -1.04% -1.04% 0.00%
1/12/2024 -2.63% -2.63% 0.00%
1/19/2024 -3.07% -3.07% 0.00%
1/26/2024 -0.64% -0.64% 0.00%
2/2/2024 -2.47% -2.14% 0.33%
2/9/2024 -2.47% -1.91% 0.56%
2/16/2024 -0.97% -0.24% 0.73%
2/23/2024 -2.63% -1.27% 1.36%
3/1/2024 -1.11% 1.04% 2.15%
3/8/2024 -1.88% 1.91% 3.79%
3/15/2024 -2.47% 0.95% 3.42%
3/22/2024 -1.86% 1.46% 3.32%
3/28/2024 0.76% 4.51% 3.75%
4/5/2024 -1.17% 1.82% 2.99%
4/12/2024 -3.51% -0.76% 2.75%
4/19/2024 -3.87% -1.29% 2.58%
4/26/2024 -1.63% 0.64% 2.27%
5/3/2024 -0.96% 1.68% 2.64%
VMI (Sorted by % Return)
Symbol % Up/Down
DRX.TO 101.01%
NMM 58.87%
ULH 51.78%
PAHC 47.41%
PRIM 42.43%
CXB.TO 41.64%
CRNT 40.74%
PRDO 38.61%
AMRK 36.60%
SCX 33.14%
BBW 30.27%
REI 30.14%
DNG.TO 28.02%
AESI 27.58%
EAT 27.33%
ARMN 25.42%
AMS 24.82%
GLGI 22.22%
RPAY 20.96%
CAL 20.31%
HIBB 20.23%
CMRE 19.88%
CPLP 17.61%
VTLE 13.54%
PPBN 13.29%
FFBB 13.19%
AMRX 11.37%
VIRT 11.25%
SKAS 10.45%
VLGEA 9.61%
NOG 8.58%
BGS 8.48%
MNDO 8.42%
DBI 7.68%
PSIX 7.32%
HHS 4.71%
PDEX 4.17%
IVR 2.82%
CRWS 2.42%
DOLE 1.22%
SAH 0.39%
MD 0.32%
EXSR 0.00%
OPY -1.19%
PLUS -2.40%
PKOH -3.30%
CBBI -3.33%
CODI -3.43%
SLRK -3.65%
RBB -4.25%
PLPC -5.31%
HASI -5.80%
CPE -5.85%
BGSF -6.17%
USMT -6.87%
INN -6.99%
AATC -7.02%
CZWI -7.09%
AVNW -8.42%
IMXI -8.78%
PMTS -8.91%
BLMN -9.02%
HRZN -10.33%
FSBW -11.26%
OPBK -11.32%
DIN -11.72%
EFSC -11.78%
MSBI -13.82%
VASO -13.97%
KOP -14.15%
ARI -14.40%
CNOB -14.93%
GIII -15.86%
FISI -16.20%
PCB -16.22%
CUBI -16.26%
IMKTA -16.29%
PKBK -16.84%
FRBA -17.21%
BZH -18.02%
FNLC -18.18%
HAFC -18.56%
SBH -18.83%
HVT -19.13%
ACCO -19.74%
CMCL -19.92%
BWFG -20.48%
ELTK -23.37%
BCBP -23.58%
TBRG -23.84%
HOT-UN.TO -26.84%
SVC -28.34%
RCMT -32.78%
HZO -33.65%
MODV -38.62%
RMAX -42.16%
CCSI -53.41%
PERI -58.34%
DTC -68.02%
AMLX -86.21%
Average Return -0.96%